OncoImmune
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
5
Funding Rounds
$76.5m
Money raised
Aria Pharmaceuticals
Aria Pharmaceuticals is a first-in-class pharmaceutical discovery and development founded in 2014 by Andrew M. Radin.
3
Funding Rounds
$14.3m
Money raised
Visterra
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
4
Funding Rounds
$153.7m
Money raised
Antidote.me
Antidote.me closes the gap between clinical trials and patients
5
Funding Rounds
$28.9m
Money raised
BlueRock Therapeutics
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
Cell Design Labs
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
Argos Therapeutics
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
2
Funding Rounds
$67.5m
Money raised
Exagen Diagnostics
A diagnostics company developing products for diagnosis, prognosis and monitoring of patients with autoimmune rheumatic diseases
3
Funding Rounds
$37.4m
Money raised
Synthorx
Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.
5
Funding Rounds
$152.0m
Money raised
Maven Biotechnologies
A life science instrumentation company developing ellipsometry analysis systems for microplates and slide disposables
1
Funding Rounds
$2.0m
Money raised
Vital Therapies, Inc.
Vital Therapies is a biotechnology company developing a cell-based therapy to treat acute liver failure.
2
Funding Rounds
$27.0m
Money raised
Kyverna Therapeutics
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Abcuro, Inc.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
4
Funding Rounds
$72.3m
Money raised
X-37
X-37 is a South San Francisco, California-based drug discovery company.
1
Funding Rounds
$14.5m
Money raised
Mogrify
Mogrify is developing tailored cellular conversions that power future cell therapies.
8
Funding Rounds
$84.5m
Money raised
Diadem Biotherapeutics
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
1
Funding Rounds
Pandion Therapeutics
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
3
Funding Rounds
$138.0m
Money raised
Delinia
Delinia is a biotechnology company that is developing novel therapeutics for treating autoimmune diseases.
2
Funding Rounds
$70.0m
Money raised
Calcimedica
Calcimedica is a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.
12
Funding Rounds
$108.1m
Money raised
Annexon Biosciences
Annexon Biosciences is a South San Francisco, California-based biotechnology company working on discovering and developing therapeutics for neurodegenerative and autoimmune disorders.
1
Funding Rounds
$44.0m
Money raised
HotSpot Therapeutics
Biotechnology company developing medicines that target allosteric regulatory sites on proteins
3
Funding Rounds
$210.0m
Money raised
DxTerity Diagnostics
DxTerity Diagnostics is a genomics company developing genomic tests for disease diagnosis and monitoring. Los Angeles-based company.
5
Funding Rounds
$4.1m
Money raised
Crescendo Bioscience
Crescendo Bioscience is a company that is developing diagnostic tools for autoimmune and inflammatory disease.
8
Funding Rounds
$235.2m
Money raised
Girihlet
Girihlet provides an immune map database. Its platform aims to accelerate immune diseases discovery, monitoring and therapeutic approaches.
4
Funding Rounds
$3.3m
Money raised
Nodality
A company developing treatments for cancer and autoimmune diseases
3
Funding Rounds
$13.5m
Money raised
Quell Therapeutics
Cell therapy firm specializing in developing treatments using advanced cellular technology.
6
Funding Rounds
$474.7m
Money raised
Lycera
A company focused on developing immunotherapy treatments for autoimmune disease and cancer
7
Funding Rounds
$123.8m
Money raised
Revolo Biotherapeutics
Therapies designed to achieve long-term disease remission with less frequent doses.
1
Funding Rounds
$40.6m
Money raised
Biond Biologics
Biond Biologics is an Israel-based immunotherapy company developing treatments for cancer and autoimmune diseases.
2
Funding Rounds
$32.0m
Money raised
Alvine Pharmaceuticals
A biotechnology company focused on the development of therapeutics for the treatmjent of autoimmune and inflammatory diseases
5
Funding Rounds
$147.5m
Money raised
Principia BioPharma
A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
2
Funding Rounds
$62.5m
Money raised
INNOVATE BIOPHARMACEUTICALS, INC.
Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma.
8
Funding Rounds
$33.4m
Money raised
Virobay
A biopharmaceutical company developing small molecule, antiviral drug treatments for the treatment of autoimmune diseases, neuropathic pain, liver diseases and cancer
1
Funding Rounds
$10.0m
Money raised
KPI Therapeutics
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.
3
Funding Rounds
$27.0k
Money raised
Ignyta
Ignyta is a company that combines medicine and biotechnology for the treatment of cancer and autoimmune diseases.
2
Funding Rounds
$59.5m
Money raised
Avila Therapeutics
A biotechnology company focused on developing covalent drugs for the treatment of cancer and other autoimmune diseases
1
Funding Rounds
$4.0m
Money raised
Amplimmune
A company developing immune-based biologics for the treatment of cancer, autoimmunity, transplantation and infectious diseases
1
Funding Rounds
$20.0m
Money raised
ImmusanT
A biotechnology company developing therapies and personalized diagnostics for celiac disease
3
Funding Rounds
$60.0m
Money raised
Janus Biotherapeutics
A company developing compounds for the treatment of autoimmune diseases
2
Funding Rounds
$5.1m
Money raised
Arrien Pharmaceuticals
A company developing targeted therapeutics for inflammation, autoimmune, oncology, neurodegenerative and central nervous system conditions
1
Funding Rounds
$2.0m
Money raised
DecImmune Therapeutics
A biotechnology company developing peptides and antibodies for inflammation and autoimmunity
2
Funding Rounds
$5.5m
Money raised
Altor BioScience
A drug discovery and development company focused on immunotherapeutic agents to treat cancer, viral infections and autoimmune diseases
2
Funding Rounds
$16.8m
Money raised
Axikin Pharmaceuticals
A biopharmaceutical company developing small molecule therapeutics for respiratory, inflammatory and autoimmune diseases
1
Funding Rounds
$3.0m
Money raised
Resolve Therapeutics
A biopharmaceutical company that develops biologic products to treat lupus and other autoimmune diseases
2
Funding Rounds
$7.8m
Money raised
NKT Therapeutics
A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
2
Funding Rounds
$12.0m
Money raised
Tolerx
A company developing therapies modulatng T-cell activities to treat autoimmune diseases, diabetes and cancer
1
Funding Rounds
$1.5m
Money raised
ImmuneWorks
A biotechnology company developing immune tolerance therapies products for the treatment of autoimmune diseases in the lung
1
Funding Rounds
$300.0k
Money raised
Virdante Pharmaceuticals
A biopharmaceutical company that develops drugs for autoimmune and inflammatory diseases
1
Funding Rounds
$30.0m
Money raised
AbGenomics
A biopharmaceutical company developing treatments and prevention for inflammatory, autoimmune disease and cancer
2
Funding Rounds
$26.5m
Money raised
ImmuVen
A company drugs for the treatment of infectious diseases, cancer and autoimmune disorders
1
Funding Rounds
$250.0k
Money raised
RadioRx
A company developing X-nitro compounds for micro treatments for cancer, inflamation, cardiovascular and autoimmune diseases
1
Funding Rounds
$20.5m
Money raised
Syntimmune
Syntimmune is a Boston-based company.
1
Funding Rounds
$50.0m
Money raised